Home / Posts Tagged "Global Critical Care"

The company has consolidated its position in GCC, ASEAN, Balkan and Caribbean regions with marketing approvals from Oman, Malaysia, Bosnia and Trinidad & Tobago for important chemotherapy drugs With this, the number of marketing approvals for its oncology products across 75 countries has gone

READ MORE

The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries Venus Remedies has been the largest exporter of meropenem from India in the last three years Riding on the upcoming

READ MORE